BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raveendran VA, Pressey JC, Woodin MA. A Novel Small Molecule Targets NKCC1 To Restore Synaptic Inhibition. Trends Pharmacol Sci 2020;41:897-9. [PMID: 33097285 DOI: 10.1016/j.tips.2020.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Löscher W, Kaila K. CNS pharmacology of NKCC1 inhibitors. Neuropharmacology 2021;:108910. [PMID: 34883135 DOI: 10.1016/j.neuropharm.2021.108910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Verma V, Kumar MJV, Sharma K, Rajaram S, Muddashetty R, Manjithaya R, Behnisch T, Clement JP. Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1+/- mice. Exp Brain Res 2021. [PMID: 34739555 DOI: 10.1007/s00221-021-06254-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]